Deep Brain Stimulation Devices Market in Huge Demand | Top Players, Application and Forecast to 2026

The Deep brain stimulation (DBS) devices market is a growing market that involves the use of implanted neurostimulation devices for the treatment of neurological and movement disorders, such as Parkinson's disease, essential tremor, and dystonia, among others. This market includes a variety of companies that offer DBS products and services, such as medical device manufacturers and healthcare providers.

The global deep brain stimulation devices market was valued at $881.9 million in 2018, and is projected to reach $2,802.6 million by 2026, registering a CAGR of 15.5%.

The global DBS devices market is expected to experience significant growth in the coming years, driven by factors such as an increasing prevalence of neurological disorders, advancements in technology, and rising demand for minimally invasive surgical procedures.

Some of the key players in the DBS devices market include companies such as Aleva Neurotherapeutics SA, Boston Scientific Corporation, Medtronic, and NeuroPace, among others.

The types of DBS devices available on the market include rechargeable and non-rechargeable devices, as well as directional and non-directional electrodes. These devices can be used to provide targeted stimulation to specific areas of the brain, improving symptoms and quality of life for patients with neurological and movement disorders.

With the growing prevalence of neurological disorders and the need for effective treatment options, the DBS devices market is expected to continue its growth trajectory in the coming years.

Increasing demand for minimally invasive surgery, adoption of technologically advanced products, and aging population drive the brain stimulation devices market as they are more susceptible to neurological disorders such as epilepsy, Parkinson's disease, Alzheimer's disease, and chronic pain. Increase in the prevalence of lifestyle diseases such as depression and chronic pain, increase in the number of neurological disorders and investment in neurological R&D are the factors driving the growth of the global deep brain stimulation devices market.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭@ https://www.alliedmarketresearch.com/request-sample/1477

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝
The Parkinson's disease segment captured the largest market share in 2018 and is expected to maintain this lead during the forecast period. Furthermore, the segment is expected to exhibit the fastest growth rate during the forecast period due to the increase in the prevalence of Parkinson's worldwide.

According to end-user, the hospital segment holds the highest deep brain stimulation device market share in 2018. In addition, this segment is expected to witness the fastest growth during the forecast period, as the number has increased. Hospitals around the world. Furthermore, neurological disorders are diagnosed and treated by professional neurologists using advanced equipment, which are available in specialized hospitals.

𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟐𝟎𝟎 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬) @ https://www.alliedmarketresearch.com/deep-brain-stimulation-devices-market

North America accounted for the major share of the deep brain stimulation devices market size and is expected to continue this trend, owing to higher number of R&D activities, presence of skilled technicians, and wide availability of technologically advanced deep brain stimulation devices. Moreover, surge in prevalence of various neurological disorders is another factor that boost the deep brain stimulation devices market in the region.

Market Research Trends Member since December 28, 2022